- Home
- CRDF vs LFMD Comparison
CRDF vs LFMD Comparison
Compare CRDF & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- LFMD
- Stock Information
- Founded
- CRDF 1999
- LFMD 1994
- Country
- CRDF United States
- LFMD United States
- Employees
- CRDF N/A
- LFMD N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- LFMD Medical/Nursing Services
- Sector
- CRDF Health Care
- LFMD Health Care
- Exchange
- CRDF Nasdaq
- LFMD Nasdaq
- Market Cap
- CRDF 240.2M
- LFMD 204.9M
- IPO Year
- CRDF N/A
- LFMD N/A
- Fundamental
- Price
- CRDF $3.45
- LFMD $4.90
- Analyst Decision
- CRDF Strong Buy
- LFMD Strong Buy
- Analyst Count
- CRDF 3
- LFMD 8
- Target Price
- CRDF $10.33
- LFMD $11.75
- AVG Volume (30 Days)
- CRDF 1.4M
- LFMD 628.4K
- Earning Date
- CRDF 02-27-2025
- LFMD 03-10-2025
- Dividend Yield
- CRDF N/A
- LFMD N/A
- EPS Growth
- CRDF N/A
- LFMD N/A
- EPS
- CRDF N/A
- LFMD N/A
- Revenue
- CRDF $688,000.00
- LFMD $193,059,114.00
- Revenue This Year
- CRDF $25.03
- LFMD $37.51
- Revenue Next Year
- CRDF N/A
- LFMD $24.87
- P/E Ratio
- CRDF N/A
- LFMD N/A
- Revenue Growth
- CRDF 49.57
- LFMD 42.16
- 52 Week Low
- CRDF $1.44
- LFMD $3.99
- 52 Week High
- CRDF $6.42
- LFMD $12.88
- Technical
- Relative Strength Index (RSI)
- CRDF 45.05
- LFMD 43.89
- Support Level
- CRDF $3.33
- LFMD $4.51
- Resistance Level
- CRDF $4.89
- LFMD $5.09
- Average True Range (ATR)
- CRDF 0.31
- LFMD 0.34
- MACD
- CRDF -0.15
- LFMD -0.03
- Stochastic Oscillator
- CRDF 10.56
- LFMD 26.17
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").
About LFMD LifeMD Inc.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.